Akoya Biosciences, Inc. (AKYA) has a consensus analyst rating of Hold, based on 9 analysts covering the stock. Of those, 2 recommend buying, 7 recommend holding, and 0 recommend selling.
The analyst consensus price target for AKYA is $2.40, representing a +86.0% upside from the current price of $1.29. Price targets range from a low of $2.40 to a high of $2.40.
